University of Toronto Reports Findings in Acute Leukemia (Differential Impact of Cd34+ Cell Dose for Different Age Groups In Allogeneic Hematopoietic Cell Trans plantation for Acute Leukemia: a Machine Learning-based Discovery)
University of Toronto Reports Findings in Acute Leukemia (Differential Impact of Cd34+ Cell Dose for Different Age Groups In Allogeneic Hematopoietic Cell Trans plantation for Acute Leukemia: a Machine Learning-based Discovery)
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Oncology - Acute Leuke mia is the subject of a report. Accordingto news originating from Toronto, Cana da, by NewsRx correspondents, research stated, “Allogeneichematopoietic cell tr ansplantation (allo-HCT) presents a potentially curative treatment for hematolog icmalignancies, yet carries associated risks and complications. Continuous rese arch focuses on predictingoutcomes and identifying risk factors.”
Key words
Toronto/Canada/North and Central Ameri ca/Acute Leukemia/Biomedicine/Cancer/Cell Transplantation/Cell Transplants/Cyborgs/Emerging Technologies/Health and Medicine/Hematology/Hematopoietic/Leukemia/Machine Learning/Oncology/Risk and Prevention/Stem Cell Transplant s/Surgery/Transplant Medicine
NETL
NSTL